ArticleMaterials today. Bio2025

ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy.

Jiayi Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.